Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019, Vensana Capital is a venture capital and growth equity investment firm based in the United States. The firm specializes in partnering with entrepreneurs to drive innovation in the healthcare sector, particularly within medical technology. With a portfolio of 20 companies, Vensana Capital has established itself as a key player in the medtech landscape. The firm focuses on development and commercial stage companies, providing them with the necessary resources and expertise to navigate the complexities of the healthcare market. Vensana Capital's reputation is built on its commitment to supporting groundbreaking advancements in healthcare, making it a sought-after partner for startups in this field.
Vensana Capital invests primarily in the healthcare sector, with a strong emphasis on medical technology. The firm targets development and commercial stage companies across various areas, including medical devices, diagnostics, data science, drug delivery, digital health, life science tools, and tech-enabled services. By focusing on these sectors, Vensana Capital aims to support innovations that can significantly impact patient care and healthcare delivery. The firm is particularly interested in companies that demonstrate a clear path to commercialization and have the potential to transform the healthcare landscape. Vensana Capital's investment strategy encompasses a range of stages, from pre-seed to growth equity, allowing them to engage with companies at different points in their development journey.
Vensana Capital has built a diverse portfolio of notable investments in the healthcare and biotech sectors. Some of the key companies in their portfolio include Abrus Bio, Apella, and PhaseBio Pharmaceuticals, which has successfully gone public. The firm has also supported several companies through acquisition, including Cartiva, CV Ingenuity, and Intact Vascular. Other significant portfolio companies include Epix Therapeutics, Personal Genome Diagnostics, Relievant Medsystems, Senseonics, Topera, Ulthera, Vertiflex, Vesper Medical, and VytronUS. With a total of 20 companies in its portfolio, Vensana Capital is actively engaged in fostering growth and innovation within the medtech space, making strategic investments that align with their mission to enhance healthcare outcomes.
Founders interested in pitching to Vensana Capital should visit their website at vensanacap.com for specific details on their pitch process. They welcome pitches from companies at various stages, and it is advisable to include a clear outline of your business model and growth strategy.
Recently, Vensana Capital has highlighted significant developments within their portfolio, including the IPO of SpyGlass Pharma and funding rounds for Ventaris Surgical and Apella. These updates reflect the firm's active engagement with its portfolio companies and their commitment to fostering innovation in the healthcare sector.
Vensana Capital invests across multiple stages, including pre-seed, seed, seed-plus, series A, series B, series C, and growth equity. This broad investment range allows them to support companies at various points in their development journey.
The firm specializes in the healthcare sector, particularly in medical technology. Their investment focus includes medical devices, diagnostics, data science, drug delivery, digital health, life science tools, and tech-enabled services.
While specific check sizes are not detailed in the source material, Vensana Capital invests across a range of stages, suggesting flexibility in their investment amounts based on the needs of the companies they support.
Vensana Capital is based in the United States and focuses its investments within the U.S. healthcare and biotech sectors.
Founders interested in pitching to Vensana Capital can visit their website at vensanacap.com for more information on their pitch process and guidelines.
Vensana Capital is actively engaged with its portfolio companies, providing support through various stages of growth. This includes strategic guidance and leveraging their extensive network to help companies navigate the healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.